Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade

Motley Fool2023-03-08

Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

541

Report

Comment（34）

烟Marlboro
·2023-03-09
Ok
Reply
1
Report
KYHBKO
·2023-03-09
There are a few assumptions made: Demand, profitability, competitive advantage remains. Costs, competition and disruptions by invocations are limited. Geopolitical factors remain favorable together with supply chain functionality and limited extreme weather. There should be no legislative impact and management remains lean & excellent. R&D is able to maintain the lead over competition. Some advantages can last for long but constant review of their operational & financial performances remain needful.
Reply
25
Report
Fold Replies
- KYHBKO:
  no advantage is permanent.
  2023-03-09
  Reply
  Report
- Khikho:
  Ok
  2023-03-09
  Reply
  Report
- Yokelee:
  Kk
  2023-03-09
  Reply
  Report
View more 2 comments
PeterLim007
·2023-03-09
👍
Reply
Like
Report
Seah CL
·2023-03-09
K
Reply
Like
Report
InvisibleP
·2023-03-09
Ok
Reply
2
Report
Khoo18
·2023-03-09
K
Reply
1
Report
PooYen
·2023-03-09
[Happy] [Happy] [Happy] [Happy] [Happy] [Happy]
Reply
1
Report
xiaobaii
·2023-03-09
like & comment please
Reply
1
Report
andrew123
·2023-03-09
Like
Reply
Like
Report
phantom74
·2023-03-09
like
Reply
Like
Report
iceage
·2023-03-09
Hii
Reply
1
Report
Janetkaneki
·2023-03-09
Likes
Reply
13
Report
Fold Replies
- xiaobaii:
  like & comment please
  2023-03-09
  Reply
  Report
Janetkaneki
·2023-03-09
Likes
Reply
12
Report
sunflower19
·2023-03-09
Nice 👍
Reply
13
Report
SanWangtikup
·2023-03-09
Thanks
Reply
10
Report
Charging Miao
·2023-03-09
👍👍👍
Reply
10
Report
Fold Replies
- FreePrincess:
  Ok
  2023-03-09
  Reply
  Report
imteng87
·2023-03-09
Ok
Reply
10
Report
Bodoh
·2023-03-09
Hahahaa useless article? Generated by AI?
Reply
8
Report
WmochaW
·2023-03-09
Thanks
Reply
9
Report
Singman
·2023-03-08
Ok
Reply
12
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2317493336?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-08 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2317493336","market":"us","top_or_hot":-1,"title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","media":"Motley Fool","content":"<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UPST","symbol_name":"Upstart Holdings, Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","article_id":"2317493336","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","pubTimestamp":1678289478,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"translate_title":"想要100万美元的退休金？2023年在这两只股票上投资20万美元，至少等十年","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISRG":0.9,"UPST":0.9},"content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9949927601,"gmtCreate":1678320909203,"gmtModify":1678320913249,"author":{"id":"4093504961888190","authorId":"4093504961888190","name":"烟Marlboro","avatar":"https://static.tigerbbs.com/828a4904cb59400c64d23755ce898bc4","vip":1,"hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"4093504961888190","idStr":"4093504961888190"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949927601","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949962697,"gmtCreate":1678316376219,"gmtModify":1678317789160,"author":{"id":"3574381076586256","authorId":"3574381076586256","name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574381076586256","idStr":"3574381076586256"},"htmlText":"There are a few assumptions made: Demand, profitability, competitive advantage remains.&nbsp; Costs,&nbsp; competition and disruptions by invocations are limited.&nbsp; Geopolitical factors remain favorable together with supply chain functionality and limited extreme weather.&nbsp; There should be no legislative impact and management remains lean &amp; excellent.&nbsp; R&amp;D is able to maintain the lead over competition.&nbsp; Some advantages can last for long but constant review of their operational &amp; financial performances remain needful.&nbsp;","listText":"There are a few assumptions made: Demand, profitability, competitive advantage remains.&nbsp; Costs,&nbsp; competition and disruptions by invocations are limited.&nbsp; Geopolitical factors remain favorable together with supply chain functionality and limited extreme weather.&nbsp; There should be no legislative impact and management remains lean &amp; excellent.&nbsp; R&amp;D is able to maintain the lead over competition.&nbsp; Some advantages can last for long but constant review of their operational &amp; financial performances remain needful.&nbsp;","text":"There are a few assumptions made: Demand, profitability, competitive advantage remains. Costs, competition and disruptions by invocations are limited. Geopolitical factors remain favorable together with supply chain functionality and limited extreme weather. There should be no legislative impact and management remains lean & excellent. R&D is able to maintain the lead over competition. Some advantages can last for long but constant review of their operational & financial performances remain needful.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":25,"commentSize":11,"repostSize":0,"link":"https://ttm.financial/post/9949962697","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105990555,"gmtCreate":1678340320133,"gmtModify":1678340323548,"authorId":3574381076586256,"author":{"id":3574381076586256,"idStr":"3574381076586256","authorId":3574381076586256,"name":"KYHBKO","avatar":"https://static.tigerbbs.com/c3bcbc7f9a10836dea92afc94bf39b5b","vip":2,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Have published 3 or more picked posts, and have published at least one picked post and participated in comments within 30 days","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.04","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":0,"categoryType":2007}]},"repliedAuthorId":0,"objectId":9949962697,"type":1,"supId":0,"prevId":0,"content":"no advantage is permanent.","text":"no advantage is permanent.","html":"no advantage is permanent."},{"id":105987209,"gmtCreate":1678322077344,"gmtModify":1678322080733,"authorId":4087214492167970,"author":{"id":4087214492167970,"idStr":"4087214492167970","authorId":4087214492167970,"name":"Khikho","avatar":"https://community-static.tradeup.com/news/ca73e504131da8c698dd9bc3f16fcd92","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949962697,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":105986795,"gmtCreate":1678318402119,"gmtModify":1678318405252,"authorId":3577294076372015,"author":{"id":3577294076372015,"idStr":"3577294076372015","authorId":3577294076372015,"name":"Yokelee","avatar":"https://community-static.tradeup.com/news/291edf044efa87e6a05284d49c6853a0","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"93.10%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949962697,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Kk</span>","text":"<span class=\"s1\">Kk</span>","html":"<span class=\"s1\">Kk</span>"},{"id":105986778,"gmtCreate":1678318371574,"gmtModify":1678318374988,"authorId":3581579760497890,"author":{"id":3581579760497890,"idStr":"3581579760497890","authorId":3581579760497890,"name":"Max77777","avatar":"https://static.itradeup.com/news/37f92566c704ebdd3ee64efdbf0d640f","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949962697,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"},{"id":105986765,"gmtCreate":1678318348016,"gmtModify":1678318351557,"authorId":3586393315819735,"author":{"id":3586393315819735,"idStr":"3586393315819735","authorId":3586393315819735,"name":"Vincent1968","avatar":"https://community-static.tradeup.com/news/7f106edb1e06baf3c68462c050422f46","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949962697,"type":1,"supId":0,"prevId":0,"content":"OK","text":"OK","html":"OK"}],"langContent":"EN"},{"id":9949966769,"gmtCreate":1678316301752,"gmtModify":1678317812688,"author":{"id":"3586816980712005","authorId":"3586816980712005","name":"PeterLim007","avatar":"https://static.tigerbbs.com/fcda5daaf1ef85159ce1d5fd2c939eea","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586816980712005","idStr":"3586816980712005"},"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949966769","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949968172,"gmtCreate":1678316029397,"gmtModify":1678317811967,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"4102135564535180","idStr":"4102135564535180"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949968172","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949960224,"gmtCreate":1678314815068,"gmtModify":1678317812016,"author":{"id":"3585470994468822","authorId":"3585470994468822","name":"InvisibleP","avatar":"https://static.itradeup.com/news/13510d2c4ac014319931fb49792d17eb","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3585470994468822","idStr":"3585470994468822"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949960224","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949960640,"gmtCreate":1678314812281,"gmtModify":1678317812213,"author":{"id":"3586514899418238","authorId":"3586514899418238","name":"Khoo18","avatar":"https://static.tigerbbs.com/a895cde27a6f60014dacbbc8853a5e1e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586514899418238","idStr":"3586514899418238"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949960640","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949960072,"gmtCreate":1678314639697,"gmtModify":1678317712969,"author":{"id":"3576743360399762","authorId":"3576743360399762","name":"PooYen","avatar":"https://static.tigerbbs.com/90f2bad6620330727869f3a5a51a046a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3576743360399762","idStr":"3576743360399762"},"htmlText":"[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;","listText":"[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;[Happy]&nbsp;","text":"[Happy] [Happy] [Happy] [Happy] [Happy] [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949960072","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949987561,"gmtCreate":1678314610454,"gmtModify":1678317712704,"author":{"id":"3571345352614779","authorId":"3571345352614779","name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3571345352614779","idStr":"3571345352614779"},"htmlText":"like &amp; comment please&nbsp;","listText":"like &amp; comment please&nbsp;","text":"like & comment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949987561","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949984485,"gmtCreate":1678314254048,"gmtModify":1678317657063,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3576260758860416","idStr":"3576260758860416"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949984485","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949985076,"gmtCreate":1678313505595,"gmtModify":1678317576176,"author":{"id":"3570342809089528","authorId":"3570342809089528","name":"phantom74","avatar":"https://static.tigerbbs.com/c87ef2af41b8696be86cceafb5b5723d","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570342809089528","idStr":"3570342809089528"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949985076","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949982471,"gmtCreate":1678313172994,"gmtModify":1678317543210,"author":{"id":"3582700442025714","authorId":"3582700442025714","name":"iceage","avatar":"https://static.tigerbbs.com/824cd9c998fb2ca537c1d47267e2f2bf","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3582700442025714","idStr":"3582700442025714"},"htmlText":"Hii","listText":"Hii","text":"Hii","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949982471","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949986096,"gmtCreate":1678311047316,"gmtModify":1678311051436,"author":{"id":"4089331589542520","authorId":"4089331589542520","name":"Janetkaneki","avatar":"https://static.tigerbbs.com/0bfbc81bb439a2790ce04b3c86fce5e1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4089331589542520","idStr":"4089331589542520"},"htmlText":"Likes","listText":"Likes","text":"Likes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9949986096","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105985843,"gmtCreate":1678314624358,"gmtModify":1678317895543,"authorId":3571345352614779,"author":{"id":3571345352614779,"idStr":"3571345352614779","authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949986096,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">like &amp; comment please<span class=\"Apple-converted-space\"> </span></span>","text":"<span class=\"s1\">like &amp; comment please<span class=\"Apple-converted-space\"> </span></span>","html":"<span class=\"s1\">like &amp; comment please<span class=\"Apple-converted-space\"> </span></span>"}],"langContent":"EN"},{"id":9949988791,"gmtCreate":1678311038513,"gmtModify":1678311042165,"author":{"id":"4089331589542520","authorId":"4089331589542520","name":"Janetkaneki","avatar":"https://static.tigerbbs.com/0bfbc81bb439a2790ce04b3c86fce5e1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4089331589542520","idStr":"4089331589542520"},"htmlText":"Likes","listText":"Likes","text":"Likes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949988791","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949988308,"gmtCreate":1678310220404,"gmtModify":1678310234309,"author":{"id":"4106158448616940","authorId":"4106158448616940","name":"sunflower19","avatar":"https://static.itradeup.com/news/f2b81b440927ad671cd053689e3da178","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4106158448616940","idStr":"4106158448616940"},"htmlText":"Nice 👍&nbsp;","listText":"Nice 👍&nbsp;","text":"Nice 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949988308","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949918904,"gmtCreate":1678295547408,"gmtModify":1678295550926,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087452914358580","idStr":"4087452914358580"},"htmlText":"Thanks&nbsp;","listText":"Thanks&nbsp;","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949918904","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949913916,"gmtCreate":1678294084935,"gmtModify":1678294090173,"author":{"id":"4103720180907530","authorId":"4103720180907530","name":"Charging Miao","avatar":"https://community-static.tradeup.com/news/d3b011c5eafabbdac7624fa875c543bc","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4103720180907530","idStr":"4103720180907530"},"htmlText":"👍👍👍","listText":"👍👍👍","text":"👍👍👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9949913916","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":105986227,"gmtCreate":1678316740152,"gmtModify":1678316743359,"authorId":3582347714998199,"author":{"id":3582347714998199,"idStr":"3582347714998199","authorId":3582347714998199,"name":"FreePrincess","avatar":"https://static.tigerbbs.com/e5875e48241b7c20bf1855e00a4224eb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9949913916,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok<span class=\"Apple-converted-space\"> </span></span>","text":"<span class=\"s1\">Ok<span class=\"Apple-converted-space\"> </span></span>","html":"<span class=\"s1\">Ok<span class=\"Apple-converted-space\"> </span></span>"}],"langContent":"EN"},{"id":9949935747,"gmtCreate":1678292386189,"gmtModify":1678292389807,"author":{"id":"3567166157226906","authorId":"3567166157226906","name":"imteng87","avatar":"https://static.tigerbbs.com/85b7b030b8b0786177d474964394bab4","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3567166157226906","idStr":"3567166157226906"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949935747","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949935324,"gmtCreate":1678292048769,"gmtModify":1678292053329,"author":{"id":"3559859558754319","authorId":"3559859558754319","name":"Bodoh","avatar":"https://static.tigerbbs.com/349218ea2852130ca86ce660b4aa2d59","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3559859558754319","idStr":"3559859558754319"},"htmlText":"Hahahaa useless article? Generated by AI?","listText":"Hahahaa useless article? Generated by AI?","text":"Hahahaa useless article? Generated by AI?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949935324","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949932151,"gmtCreate":1678291244773,"gmtModify":1678291248829,"author":{"id":"4091003553110310","authorId":"4091003553110310","name":"WmochaW","avatar":"https://community-static.tradeup.com/news/f4e4f187a1d821471f2ca84a5b1a1529","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4091003553110310","idStr":"4091003553110310"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949932151","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9949939075,"gmtCreate":1678287903097,"gmtModify":1678287907063,"author":{"id":"3575125836760247","authorId":"3575125836760247","name":"Singman","avatar":"https://static.tigerbbs.com/d770feb757705f2d631d2d5f381ae07b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3575125836760247","idStr":"3575125836760247"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949939075","repostId":2317493336,"repostType":4,"repost":{"id":"2317493336","pubTimestamp":1678289478,"share":"https://ttm.financial/m/news/2317493336?lang=&edition=fundamental","pubTime":"2023-03-08 23:31","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2317493336","media":"Motley Fool","summary":"No one can predict the future, but a long-term investment in a diverse collection of wonderful businesses can build a market-beating portfolio with time.","content":"<html><head></head><body><p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn&#39;t happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.</p><p>That said, if you&#39;re looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.</p><h2>1. Upstart</h2><p><b>Upstart</b> is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.</p><p>In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart&#39;s institutional partners -- who, in the past, have bought the lion&#39;s share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart&#39;s model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.</p><p>So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it&#39;s had to aggressively scale back costs, including in the form of layoffs.</p><p>While this is a tough moment for Upstart and its investors, I think it&#39;s far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart&#39;s contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart&#39;s platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.</p><p>Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart&#39;s platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.</p><p>For risk-tolerant investors with cash to put to work right now, Upstart&#39;s current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it&#39;s still beaten down.</p><h2>2. Intuitive Surgical</h2><p><b>Intuitive Surgical</b> has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.</p><p>The adoption of surgical robotic systems within the medical community continues to increase, and it&#39;s estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.</p><p>Beyond the company&#39;s first-mover advantage in its industry, however, the way in which Intuitive Surgical&#39;s business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.</p><p>Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.</p><p>And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.</p><p>The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $200,000 in These 2 Stocks in 2023 and Wait at Least a Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-08 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2023/03/07/want-1-million-in-retirement-invest-200000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2317493336","content_text":"Even if your retirement is still many years in the future, the steps you take now to build your portfolio could have a significant impact on the returns you enjoy in your later years. Building a retirement portfolio worth $1 million or more doesn't happen overnight. It takes time, patience, diversification, rebalancing, and a consistent pattern of investing in great companies in both up and down markets and holding on to them for many years to accumulate those kinds of returns.That said, if you're looking for explosive businesses to add to your portfolio right now, here are two supercharged stocks with superior growth potential that could foreseeably multiply $200,000 by five times or more in the next decade and beyond.1. UpstartUpstart is dealing with a perfect storm in terms of the confluence of challenges it is up against in the current market. Driven by artificial intelligence (AI), the platform acts as a loan marketplace. It uses its proprietary model, which factors in over 1,000 data points (and not just the traditional FICO score), to determine whether to approve various types of consumer loans. Upstart partners with lending institutions nationwide, deriving most of its revenue from fees for the loans it services. So the more loan volume Upstart processes, the more money it makes.In the current environment, however, the typical process by which Upstart operates its business has faced interruptions. For one, fewer people are applying for loans right now, particularly with interest rates being so high. And because interest rates are so high, the cost that Upstart's institutional partners -- who, in the past, have bought the lion's share of all loans processed through the platform -- incur to fund these loans has led many to reduce or pause originations altogether. Upstart's model, which continues to learn and attune to the economic environment at hand, is also approving fewer loans.So with loan volume depressed and Upstart being forced to carry far more loans on its balance sheet than usual, revenue has dropped, the company is currently unprofitable, and it's had to aggressively scale back costs, including in the form of layoffs.While this is a tough moment for Upstart and its investors, I think it's far too soon to say all is lost. Case in point: Even though lending volume dropped 14% in 2022 compared to 2021, Upstart's contribution profit actually rose by almost the same amount (13%) from the prior year. Moreover, the underlying technology behind Upstart's platform -- which remains its greatest competitive advantage -- is continuing to prove its efficacy, with management noting that its model accuracy improved more in the seven months leading up to the end of 2022 than in the entire 30 months before that.Even now, with institutions scaling back loan originations, more lending partners are continuing to jump on the Upstart bandwagon, its cohort of bank and credit union partners skyrocketing 120% in the 12-month period alone. With a growing network of lending partners and Upstart's platform rapidly learning and calibrating to the current environment, this could lay the groundwork for a robust recovery in conditions where the risk of default and interest rates are lower.For risk-tolerant investors with cash to put to work right now, Upstart's current discounted price could present a timely opportunity to buy shares of a highly promising business in the early stages of growth while it's still beaten down.2. Intuitive SurgicalIntuitive Surgical has dominated the surgical robotics industry for over two decades now, ever since the approval of its flagship system, the da Vinci surgical suite. The system is used in a wide range of minimally invasive surgical procedures. The company also now sells another surgical system, called the Ion, used in lung biopsies.The adoption of surgical robotic systems within the medical community continues to increase, and it's estimated that this industry will surpass a valuation of nearly $20 billion by the year 2030. Meanwhile, as of 2021, Intuitive Surgical controlled about 80% of this global industry. Although the company is not without competition, no competitor has even come close to snagging this level of market share.Beyond the company's first-mover advantage in its industry, however, the way in which Intuitive Surgical's business is designed has enabled the company to grow revenue and profits in a wide range of business and economic environments. Beyond the initial sales of its surgical systems, the company makes recurring revenue from services such as medical provider training on how to use its products, customer support, and replacement tools and instruments that accompany its systems.Over the past 10 years, Intuitive Surgical has witnessed its revenue and earnings grow by respective clips of 175% and 97%. During that same time, the company improved its cash from operations by 70%.And investors who stayed with the stock that entire time have benefited from a total return of over 300%. Intuitive Surgical has dealt with a slowdown in procedure volume in recent quarters as COVID-19 resurgences in key markets resulted in surgery delays and cancellations. However, the company is still profitable, revenue is growing steadily, and its installed base of systems continues to grow.The company had 7,544 systems installed worldwide at the end of 2022, up 35% compared to the end of 2019. The healthcare stock has plenty of room left to run as procedure volumes normalize and adoption of its products continues to grow, both factors that could induce long-term investors to consider a position in this resilient healthcare business.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":541,"commentSize":34,"repostSize":0,"favoriteSize":5,"likeStatus":false,"favoriteStatus":false}}